Surgical decisions should not be based solely on MRI findings because not all suspicious lesions on MRI are cancer, and suspicious lesions should be biopsied before a surgical plan is devised in order to avoid surgical overtreatment, according to guidelines published in the Journal of the National Comprehensive Cancer Network.
Surgical decisions should not be based solely on MRI findings because not all suspicious lesions on MRI are cancer, and suspicious lesions should be biopsied before a surgical plan is devised in order to avoid surgical overtreatment, according to guidelines published in the Journal of the National Comprehensive Cancer Network.
Among the recommendations is that MRI is not a substitute for screening or diagnostic mammography and, when indicated, diagnostic breast ultrasound, the guidelines state. But when cancer is found in the lymph nodes but not the breast, MRI can find the location of cancer in the breast in nearly 60% of women.
The guidelines were developed by Dr. Constance Lehman, a professor of radiology at the University of Washington and director of breast imaging at Seattle Cancer Care Alliance, and colleagues. They were based on an extensive review of published, peerreviewed studies.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.